Press "Enter" to skip to content

2012 is the time for Gene Therapy to Start to get Disruptive

Via Scoop.itDemand Transformation

Christensen’s research suggests there may be impediments to this happening, based on what he calls the “Innovator’s Dilemma,” which is best described by the following question: “How [can] executives…simultaneously do what is right for the near-term health of their established businesses, while focusing adequate resources on the disruptive technologies that ultimately could lead to their downfall?”